Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease

Abstract Background The human gut microbiome performs important functions in human health and disease. A classic example for host-gut microbial co-metabolism is host biosynthesis of primary bile acids and their subsequent deconjugation and transformation by the gut microbiome. To understand these sy...

Full description

Bibliographic Details
Main Authors: Almut Heinken, Dmitry A. Ravcheev, Federico Baldini, Laurent Heirendt, Ronan M. T. Fleming, Ines Thiele
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Microbiome
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40168-019-0689-3
_version_ 1818041884195422208
author Almut Heinken
Dmitry A. Ravcheev
Federico Baldini
Laurent Heirendt
Ronan M. T. Fleming
Ines Thiele
author_facet Almut Heinken
Dmitry A. Ravcheev
Federico Baldini
Laurent Heirendt
Ronan M. T. Fleming
Ines Thiele
author_sort Almut Heinken
collection DOAJ
description Abstract Background The human gut microbiome performs important functions in human health and disease. A classic example for host-gut microbial co-metabolism is host biosynthesis of primary bile acids and their subsequent deconjugation and transformation by the gut microbiome. To understand these system-level host-microbe interactions, a mechanistic, multi-scale computational systems biology approach that integrates the different types of omic data is needed. Here, we use a systematic workflow to computationally model bile acid metabolism in gut microbes and microbial communities. Results Therefore, we first performed a comparative genomic analysis of bile acid deconjugation and biotransformation pathways in 693 human gut microbial genomes and expanded 232 curated genome-scale microbial metabolic reconstructions with the corresponding reactions (available at https://vmh.life). We then predicted the bile acid biotransformation potential of each microbe and in combination with other microbes. We found that each microbe could produce maximally six of the 13 secondary bile acids in silico, while microbial pairs could produce up to 12 bile acids, suggesting bile acid biotransformation being a microbial community task. To investigate the metabolic potential of a given microbiome, publicly available metagenomics data from healthy Western individuals, as well as inflammatory bowel disease patients and healthy controls, were mapped onto the genomes of the reconstructed strains. We constructed for each individual a large-scale personalized microbial community model that takes into account strain-level abundances. Using flux balance analysis, we found considerable variation in the potential to deconjugate and transform primary bile acids between the gut microbiomes of healthy individuals. Moreover, the microbiomes of pediatric inflammatory bowel disease patients were significantly depleted in their bile acid production potential compared with that of controls. The contributions of each strain to overall bile acid production potential across individuals were found to be distinct between inflammatory bowel disease patients and controls. Finally, bottlenecks limiting secondary bile acid production potential were identified in each microbiome model. Conclusions This large-scale modeling approach provides a novel way of analyzing metagenomics data to accelerate our understanding of the metabolic interactions between the host and gut microbiomes in health and diseases states. Our models and tools are freely available to the scientific community.
first_indexed 2024-12-10T08:37:31Z
format Article
id doaj.art-dcf614623d0b44eeaf0e6e3d45e6b03b
institution Directory Open Access Journal
issn 2049-2618
language English
last_indexed 2024-12-10T08:37:31Z
publishDate 2019-05-01
publisher BMC
record_format Article
series Microbiome
spelling doaj.art-dcf614623d0b44eeaf0e6e3d45e6b03b2022-12-22T01:55:57ZengBMCMicrobiome2049-26182019-05-017111810.1186/s40168-019-0689-3Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel diseaseAlmut Heinken0Dmitry A. Ravcheev1Federico Baldini2Laurent Heirendt3Ronan M. T. Fleming4Ines Thiele5School of Medicine, National University of Ireland, GalwaySchool of Medicine, National University of Ireland, GalwayLuxembourg Centre for Systems Biomedicine, University of LuxembourgLuxembourg Centre for Systems Biomedicine, University of LuxembourgDivision of Analytical Biosciences, Leiden Academic Centre for Drug Research, Faculty of Science, University of LeidenSchool of Medicine, National University of Ireland, GalwayAbstract Background The human gut microbiome performs important functions in human health and disease. A classic example for host-gut microbial co-metabolism is host biosynthesis of primary bile acids and their subsequent deconjugation and transformation by the gut microbiome. To understand these system-level host-microbe interactions, a mechanistic, multi-scale computational systems biology approach that integrates the different types of omic data is needed. Here, we use a systematic workflow to computationally model bile acid metabolism in gut microbes and microbial communities. Results Therefore, we first performed a comparative genomic analysis of bile acid deconjugation and biotransformation pathways in 693 human gut microbial genomes and expanded 232 curated genome-scale microbial metabolic reconstructions with the corresponding reactions (available at https://vmh.life). We then predicted the bile acid biotransformation potential of each microbe and in combination with other microbes. We found that each microbe could produce maximally six of the 13 secondary bile acids in silico, while microbial pairs could produce up to 12 bile acids, suggesting bile acid biotransformation being a microbial community task. To investigate the metabolic potential of a given microbiome, publicly available metagenomics data from healthy Western individuals, as well as inflammatory bowel disease patients and healthy controls, were mapped onto the genomes of the reconstructed strains. We constructed for each individual a large-scale personalized microbial community model that takes into account strain-level abundances. Using flux balance analysis, we found considerable variation in the potential to deconjugate and transform primary bile acids between the gut microbiomes of healthy individuals. Moreover, the microbiomes of pediatric inflammatory bowel disease patients were significantly depleted in their bile acid production potential compared with that of controls. The contributions of each strain to overall bile acid production potential across individuals were found to be distinct between inflammatory bowel disease patients and controls. Finally, bottlenecks limiting secondary bile acid production potential were identified in each microbiome model. Conclusions This large-scale modeling approach provides a novel way of analyzing metagenomics data to accelerate our understanding of the metabolic interactions between the host and gut microbiomes in health and diseases states. Our models and tools are freely available to the scientific community.http://link.springer.com/article/10.1186/s40168-019-0689-3Gut microbiomeBile acidsHost-microbe interactionsMetabolismGenome-scale reconstructionConstraint-based modeling
spellingShingle Almut Heinken
Dmitry A. Ravcheev
Federico Baldini
Laurent Heirendt
Ronan M. T. Fleming
Ines Thiele
Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
Microbiome
Gut microbiome
Bile acids
Host-microbe interactions
Metabolism
Genome-scale reconstruction
Constraint-based modeling
title Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
title_full Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
title_fullStr Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
title_full_unstemmed Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
title_short Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
title_sort systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
topic Gut microbiome
Bile acids
Host-microbe interactions
Metabolism
Genome-scale reconstruction
Constraint-based modeling
url http://link.springer.com/article/10.1186/s40168-019-0689-3
work_keys_str_mv AT almutheinken systematicassessmentofsecondarybileacidmetabolismingutmicrobesrevealsdistinctmetaboliccapabilitiesininflammatoryboweldisease
AT dmitryaravcheev systematicassessmentofsecondarybileacidmetabolismingutmicrobesrevealsdistinctmetaboliccapabilitiesininflammatoryboweldisease
AT federicobaldini systematicassessmentofsecondarybileacidmetabolismingutmicrobesrevealsdistinctmetaboliccapabilitiesininflammatoryboweldisease
AT laurentheirendt systematicassessmentofsecondarybileacidmetabolismingutmicrobesrevealsdistinctmetaboliccapabilitiesininflammatoryboweldisease
AT ronanmtfleming systematicassessmentofsecondarybileacidmetabolismingutmicrobesrevealsdistinctmetaboliccapabilitiesininflammatoryboweldisease
AT inesthiele systematicassessmentofsecondarybileacidmetabolismingutmicrobesrevealsdistinctmetaboliccapabilitiesininflammatoryboweldisease